DLL4-binding molecules

Details for Australian Patent Application No. 2010302587 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Borges, Eric; Gschwind, Andreas; Boucneau, Joachim; De Tavernier, Evelyn; Kolkman, Joost; Merchiers, Pascal; Van Hoorick, Diane

Agent Spruson & Ferguson

Pub. Number AU-A-2010302587

PCT Pub. Number WO2011/039368

Priority 09172132.4 02.10.09 EP

Filing date 1 October 2010

Wipo publication date 7 April 2011

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039368 Priority application(s): WO2011/039368

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302589-Bispecific binding molecules for antiangiogenesis therapy

2010302586-Pharmaceutical compositions comprising BI-1356 and metformin